Today is Sunday, Mar. 29, 2020

Department of Internal Medicine

Hematology & Oncology

Photo of  Emily Curran, MD

Emily Curran, MD

Assistant Professor

  • BA: Stanford University
  • MD: Stanford University School of Medicine
  • Residency: University of Chicago Medical Center
  • Fellowship: University of Chicago Medical Center
  • Fellowship: University of Chicago
Contact Information

Peer Reviewed Publications

Curran, Emily; Stock, Wendy 2019. Taking a "BiTE out of ALL": blinatumomab approval for MRD-positive ALL. Blood, 133 16, 1715-1719

Wang, Amy Y; Weiner, Howard; Green, Margaret; Chang, Hua; Fulton, Noreen; Larson, Richard A; Odenike, Olatoyosi; Artz, Andrew S; Bishop, Michael R; Godley, Lucy A; Thirman, Michael J; Kosuri, Satyajit; Churpek, Jane E; Curran, Emily; Pettit, Kristen; Stock, Wendy; Liu, Hongtao 2018. A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia. Journal of hematology & oncology, 11 1, 4

Curran, Emily K; Godfrey, James; Kline, Justin 2017. Mechanisms of Immune Tolerance in Leukemia and Lymphoma. Trends in immunology, 38 7, 513-525

Yap, Kai Lee; Furtado, Larissa V; Kiyotani, Kazuma; Curran, Emily; Stock, Wendy; McNeer, Jennifer L; Kadri, Sabah; Segal, Jeremy P; Nakamura, Yusuke; Le Beau, Michelle M; Gurbuxani, Sandeep; Raca, Gordana 2017. Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL). Leukemia & lymphoma, 58 4, 950-958

Curran, Emily; Chen, Xiufen; Corrales, Leticia; Kline, Douglas E; Dubensky, Thomas W; Duttagupta, Priyanka; Kortylewski, Marcin; Kline, Justin 2016. STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia. Cell reports, 15 11, 2357-66

Curran, Emily; Corrales, Leticia; Kline, Justin 2015. Targeting the innate immune system as immunotherapy for acute myeloid leukemia. Frontiers in oncology, 5 , 83

Curran, Emily; Stock, Wendy 2015. How I treat acute lymphoblastic leukemia in older adolescents and young adults. Blood, 125 24, 3702-10

Curran, Emily; Smith, Sonali M 2014. Phosphoinositide 3-kinase inhibitors in lymphoma. Current opinion in oncology, 26 5, 469-75

Jain, Nitin; Curran, Emily; Iyengar, Neil M; Diaz-Flores, Ernesto; Kunnavakkam, Rangesh; Popplewell, Leslie; Kirschbaum, Mark H; Karrison, Theodore; Erba, Harry P; Green, Margaret; Poire, Xavier; Koval, Greg; Shannon, Kevin; Reddy, Poluru L; Joseph, Loren; Atallah, Ehab L; Dy, Philip; Thomas, Sachdev P; Smith, Scott E; Doyle, L Austin; Stadler, Walter M; Larson, Richard A; Stock, Wendy; Odenike, Olatoyosi 2014. Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 20 2, 490-8

Curran, Emily K; Le, Gem M; Sainani, Kristin L; Propp, Jennifer M; Fisher, Paul Graham 2009. Do children and adults differ in survival from medulloblastoma? A study from the SEER registry. Journal of neuro-oncology, 95 1, 81-85

Curran, Emily K; Sainani, Kristin L; Le, Gem M; Propp, Jennifer M; Fisher, Paul G 2009. Gender affects survival for medulloblastoma only in older children and adults: a study from the Surveillance Epidemiology and End Results Registry. Pediatric blood & cancer, 52 1, 60-4

Partap, Sonia; Curran, Emily K; Propp, Jennifer M; Le, Gem M; Sainani, Kristin L; Fisher, Paul Graham 2009. Medulloblastoma incidence has not changed over time: a CBTRUS study. Journal of pediatric hematology/oncology, 31 12, 970-1